Antibodies to squalene in Gulf War Syndrome

Experimental and Molecular Pathology

Volumn 68, Issue 1, 2000, Pages 55-64

  Asa, Pamela B ^a   Cao, Yan ^a   Garry, Robert F ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; SQUALENE;

ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CHRONIC FATIGUE SYNDROME; CONTROLLED STUDY; HUMAN; PERSIAN GULF SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0033974771     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1006/exmp.1999.2295     Document Type: Article

References (68)

1. Abou-Donia M., Wilmarth K., Jensen K., Oehme F., Kurt T. Neurotoxicity resulting from coexposure to pyridostygmine bromide, deet, and permethrine: Implications of Gulf War chemical exposures. J. Toxicol. Environ. Health. 48:1996;5-56.
2. Akira S., Hirano T., Taga T., Kishimoto T. Biology of multifunctional cytokines: IL6 and related molecules (IL1 and TNF). FASEB J. 4:1990;2860-2867.
3. Allison A., Byars N. Immunological adjuvants: Desirable properties and side effects. Mol. Immunol. 28:1991;279-284.
4. Alving C. R., Swartz G. M. Jr. Antibodies to cholesterol, cholesterol conjugates and liposomes: Implications for atherosclero sis and autoimmunity. Crit. Rev. Immunol. 10:1991;441-453.
5. Alving C. R., Swartz G. M. Jr., Wassef N. M. Naturally occurring autoantibodies to cholesterol in humans. Biochem. Soc. Trans. 17:1989;637-639.
6. Alving C. R., Wassef N. M., Potter M. Antibodies to cholesterol: Biological implication of antibodies to lipids. Curr. Top. Microbiol. Immunol. 210:1996;181-186.
7. Bansal A., Abdul Karim B., Malik R. A., Goulding P., Pumphrey R. S., Boulton A. J., Holt P. L., Wilson P. B. IgM ganglioside GM1 antibodies in patients with autoimmune disease and neuropathy, and controls. J. Clin. Pathol. 47:1994;300-302.
8. Beck F. W., Whitehouse M. W. Modifications in the establishment of allergic encephalomyelitis (EAE) in rats: An improved assay for immunosuppressive drugs. Agents Actions. 6:1976;460-467.
9. Brautbar N., Campbell A., Vojdani A. Silicone breast implants and autoimmunity: Causation, association, or myth? J. Biomater. Sci. Polym. Ed. 7:1995;133-145.
10. Bridges A. J., Conley C., Wang G., Burns D. E., Vasey F. B. A clinical and immunological evaluation of women with silicone breast implants and symptoms of rheumatic disease. Ann. Intern. Med. 118:1993;929-936.
11. Burke R., Goldbeck C., Ng P., Stanberry L., Ott G., Van Nest G. Influence of adjuvant on the therapeutic efficiency of a recombinant genital herpes vaccine. J. Infect. Dis. 170:1994;1110-1119.
12. Clemons J., Brout B. Testicular dysfunction in the adju vant-induced arthritic rat. J. Androl. 10:1989;419-421.
13. Coker W. J., Bhatt B. M., Blatchley N., Graham J. T. Clinical findings for the first 1000 Gulf War veterans in the Ministry of Defence's medical assessment programme. BMJ. 318:1999;290-294.
14. Cross A., Raine C. Central nervous system endothelial cell-polymorphonuclear cell interaction during autoimmune demyelinization. Am. J. Pathol. 139:1991;1401-1409.
15. David A., Ferry S., Wessely S. Gulf War illness. BMJ. 314:1997;239-240.
16. Dijkstra J., Swartz G. M. Jr., Raney J. J., Aniagolu J., Toro L., Nacy C. A., Green S. J. Interactions of anti-cholesterol antibodies with human lipoproteins. J. Immunol. 157:1996;2006-2013.
17. Dinarello C. A. Biology of interleukin 1. FASEB J. 2:1988;108-115.
18. Fitzpatrick J., Koh J., Hartwell D., Beller D., Levine J. S. Dysregulated cytokine expression in vivo in predisposed and autoimmune-prone MLR mice. Autoimmunity. 23:1996;217-229.
19. Fukuda K., Nisenbaum R., Stewart G., Thompson W. W., Robin L., Washko R. A., Noah D. L., Barrett D. H., Randall B., Herwaldt B. L., Mawle A. C., Reeves W. C. Chronic multisystem disease affecting Air Force veterans of the Gulf War. J. Am. Med. Assoc. 280:1998;981-988.
20. Garrett I. R., Whitehouse M. W., Vernon Roberts B., Brooks P. M. Ambivalent properties of gold drugs in adjuvant-induced polyarthritis in rats. J. Rheumatol. 12:1985;1079-1082.
21. Geirsson A., Steinsson K., Guomuddsson S., Sigurosson V. Systemic sclerosis in Iceland: A national epidemiological study. Ann. Rheum. Dis. 53:1994;502-505.
22. Grady E. P., Carpenter M., Koenig C., Older S., Battafarano D. F. Rheumatic findings in Gulf War veterans. Arch. Intern. Med. 158:1998;367-371.
23. Gylling H., Miettinen T. A. Postabsorptive metabolism of dietary squalene. Atherosclerosis. 106:1994;169-178.
24. Haley R. W. Is Gulf War syndrome due to stress? The evidence reexamined. Am. J. Epidemiol. 146:1997;695-703.
25. Haley R. W., Kurt T. L. Self-reported exposure to neurotoxic chemical combinations in the Gulf War. A cross-sectional epidemiologic study. J. Am. Med. Assoc. 277:1997;231-237.
26. Hoffman S., Eaelman R., Bryan J. P., Schneider I., Davis J., Sedegan M., Gordon D., Church P., Gross M., Silverman C. Safety, immunogenicity, and efficacy of a malaria sporozoite vaccine administered with monophosphoryl lipid A, cell wall cytoskeleton of mycobacteria, and squalene as adjuvant. Am. J. Trop. Med. Hyg. 51:1994;603-612.
27. Honnorat J., Trouillas P., Thivolet C., Aquera M., Belin M. Autoantibodies to glutamate decarboxylase in a patient with cerebellar atrophy, peripheral neuropathy and slow eye movement. Arch. Neurol. 52:1995;462-468.
28. Hyams K. C., Wignall S., Roswell R. War syndromes and their evaluation: From the U.S. Civil War to the Persian Gulf War. Ann. Intern. Med. 125:1996;398-405.
29. Ismail K., Everitt B., Blatchley N., Hull L., Unwin C., David A., Wesseley S. Is there a Gulf War syndrome? Lancet. 353:1999;179-182.
30. Ivins B., Fellows P., Pix L., Estep J., Farchaus J., Friedlander A., Gibbs P. Experimental anthrax vaccines: Efficacy of adjuvants combined with protective antigen against aerosol Bacillus anthracis spore challenge in guinea pigs. Vaccine. 131:1995;1779-1783.
31. Keefer M., Graham B. S., McElrath M. J., Matthews T. J., Stablein D. M., Corey L., Wright P. F., Lawrence D., Fast P. E., Weinhold K., Hsich R. H., Chernoff D., Dekker C., Dolin R. Safety and immunogenicity of Env 2-3, a human immunodeficiancy virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF-59. AIDS Res. Hum. Retroviruses. 12:1996;683-693.
32. Keutek W., Couch R., Bond N., Adair S., Van Nest G., Dekker C. Pilot evaluation of influenza virus vaccine (IVV) combined with adjuvant. Vaccine. 11:1993;909-913.
33. Kleinau S., Lorentzen J., Klareskog L. Role of adjuvants in turning autoimmunity into autoimmune disease. Scand. J. Rheumatol. Suppl. 101:1995;179-181.
34. Kohashi O., Pearson M., Beck F. J., Alexander M. Effect of oil composition on both adjuvant induced arthritis and delayed hypersensitivity to purified protein derivative and peptidoglycans in various rat strains. Infect. Immun. 17:1977;244-249.
35. Koga T., Kakimoto K., Hirofuji T., Kotani S., Sumiyoshi A., Saisho K. Muramyl dipeptide induces acute joint inflammation in the mouse. Microbiol. Immunol. 30:1986;717-723.
36. Lorentzen J. C. Identification of arthritogenic adjuvants of self and foreign origin. Scand. J. Immunol. 49:1999;45-50.
37. Lorentzen J. C., Olssen T., Klareskog L. Susceptibility to oil-induced arthritis in the DA rat is determined by MHC and non-MHC genes. Transplant. Proc. 27:1995;1532-1534.
38. Madzhidov U. V., Blandova Z. K., Madzhidov A. V. Genetic control of sensitivity to experimental adjuvant arthritis in mice of inbred lines. Buill. Eksp. Biol. Med. 102:1986;74-76.
39. McNicholl J., Glynn D., Mongey A., Hutchinson M., Bresnihan B. A prospective study of neurophysiologic, neurologic, and immunologic abnormalities in systemic lupus erythematosus. J. Rheumatol. 21:1994;1061-1066.
40. Michet C., McKenna C., Elveback L., Kaslow R., Kurland L. Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin. Proc. 60:1985;105-113.
41. Moll J., Markusse H., Pijnenburg J., Vecht C., Henzen-Logmans S. Antineuronal antibodies in patients with neurological complications of primary Sjogren's syndrome. Neurology. 43:1993;2574-2581.
42. Naim J. O., Ippolito K. M., Van Oss C. J. Adjuvancy effect of different types of silicone gel. J. Biomed. Mater. Res. 37:1997;534-538.
43. Nicholson J. Jr., Hill S. L., Frondoza C. G., Rose N. R. Silicone gel and octamethylcyclotetrasiloxane (D4) enhances anti body production to bovine serum albumin in mice. J. Biomed. Mater. Res. 31:1996;345-353.
44. Arch. Intern. Med. 155:1995;262-268.
45. Petty R., Johnston W., McCormick A., Hunt D., Rootman, Rollins J. D. Uveitis and arthritis induced by adjuvant: Clinical, immunological, and histological characteristics. J. Rheumatol. 16:1989;400-405.
46. Rofe A., Philcox J., Haynes D., Coyle P. Wasting in adjuvant-induced arthritis and its relationship to plasma zinc, copper, and liver metallothionein. Agents Actions. 42:1994;60-62.
47. Rogers S., Twyman R., Gahring L. The role of autoimmunity to glutamate receptors in neurological disease. Mol. Med. Today. 2:1996;76-81.
48. Rook G. A., Zumia A. Gulf War Syndrome: Is it due to a systemic shift in cytokine balance towards a Th2 profile? Lancet. 349:1997;1831-1833.
49. Rook G. A., Zumia A. Is the Gulf War Syndrome an immunologically mediated phenomenon? Hosp. Med. 59:1998;10-11.
50. Sergott T. J., Limoli J. P., Baldwin C. M. Jr., Laub D. R. Human adjuvant disease, possible autoimmune disease after silicone implantation: A review of the literature, case studies, and speculation for the future. Plast. Reconstr. Surg. 78:1986;104-114.
51. Stamellos K. D., Shackleford J. E., Shechter I., Jiang G., Conrad D., Keller G. A., Krisan S. K. Subcellular localization of squalene synthase in rat hepatic cells. Biochemical and immunological evidence. J. Biol. Chem. 268:1993;12825-12836.
52. Strandberg T. E., Tilvis R. S., Miettinen T. A. Metabolic variables of cholesterol during squalene feeding in humans: Comparison with cholestryramine treatment. J. Lipid Res. 31:1990;1637-1643.
53. Straus S. E. Bridging the gulf in war syndrome. Lancet. 353:1999;162-163.
54. Swartz G. M., Gentry M. K., Amende L. M., Blanchette Mackie E. J., Alving C. R. Antibodies to cholesterol. Proc. Natl. Acad. Sci. USA. 85:1988;1902-1906.
55. Tekin S., Aykut C., Ozgun S., Aktan S. The role of autoimmunity in vascular dementia. Dementia. 7:1996;91-94.
56. Tenenbaum S. A., Rice J. C., Espinoza L. R., Cuellar M. L., Plymak D. R., Sander D. M., Williamson L. L., Haislip A. M., Gluck O. S., Tesser J. R. Use of antipolymer antibody assay in recipients of silicone breast implants. Lancet. 349:1997;449-454.
57. Tilvis R. S., Miettinen T. A. Absorption and metabolic fate of dietary 3H-squalene in the rat. Lipids. 18:1983;233-238.
58. Unwin C., Blatchley N., Coker W., Ferry S., Hotopf M., Hull L., Ismail K., Palmer I., David A., Wessely S. Health of UK servicemen who served in Persian Gulf War. Lancet. 353:1999;169-178.
59. Valensi J., Carlson J., Van Nest G. Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF-59 oil emulsion and other advanced adjuvants. J. Immunol. 153:1994;4029-4039.
60. Van der Meide P., Schellekens H. Cytokines and immune response. Biotherapy. 8:1996;243-249.
61. Vaslin B., LeGrand R., Vogt G., Roques P., Stoekel P., Salk J., Dormant D. Purified inactivated SIV vaccine: Comparison of adjuvants. Int. Conf. AIDS. 8:1992.
62. Whitehouse M. W., Orr K. J., Beck F. W., Pearson C. M. Freund's adjuvants: Relationship of arthritigenicity and adjuvanticity in rats to vehicle composition. Immunology. 27:1974;311-330.
63. Wolford L. Temperomandibular joint devices: Treatment factors and outcomes. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 83:1997;143-149.
64. Wucherpfennig K., Weiner H. L. Immunological mechanisms in chronic demyelinating diseases of the central and peripheral nervous system. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 68:1990;105-116.
65. Yoshida S. H., Teuber S. S., German J. B., Gershwin M. E. Immunotoxicity of silicone: Implications of oxidant balance towards adjuvant activity. Food Chem. Toxicol. 32:1994;1089-1100.
66. Yoshino S., Yoshino J. Recruitment of pathogenic T cells to synovial tissues of rats injected intraarticularly with nonspecific agents. Cell. Immunol. 158:1994;305-313.
67. Zamma T. Adjuvant-induced arthritis in the temperomandibu lar joint in rats. Infect. Immun. 39:1983;1291-1299.
68. Zanone M., Peakman M., Purewal T., Watkins P., Vergani D. Autoantibodies to nervous tissue structures are associated with autonomic neuropathy in type I (insulin-dependent) diabetes mellitus. Diabetologia. 36:1993;564-569.